AlphaMadera's AlphaVal page computes AT&T Inc.'s fair value using a multi-method blend (DCF, comparable-multiples, and Graham-style intrinsic value), then compares it to the current market price to flag T as undervalued, fairly valued, or overvalued.

What is AT&T Inc.'s fair value?

Fair value for T is a model output combining discounted cash flow projections, peer-group multiples, and a Graham number floor. The live AlphaVal page shows the blended fair value alongside each method's individual estimate.

How does AlphaMadera value T?

AlphaVal uses three primary techniques: a five-year discounted-cash-flow projection with terminal multiple, peer-group multiple analysis (P/E, EV/EBITDA, P/S), and Graham's defensive-investor intrinsic-value formula. Inputs come from T's most recent reported fundamentals.

T - AT&T Inc.

Price: -- -- | CONSENSUS: Hold DETAILS | PRICE TARGET: $27.13 DETAILS

AlphaVal

Deterministic, archetype-aware fair value

Stable Earnings Power 65% confidence

Primary model: P/Adj-EPS × Normalized Multiple

Valuation Signal Undervalued Strong

Trading 41.0% below fair value

Current Price $23.70

Bear Case $32.12 35.5% upside ($32.12 - $23.70) / $23.70 = 35.5% $3.11 × 12x P/E

Fair Value $40.15 69.4% upside ($40.15 - $23.70) / $23.70 = 69.4% $3.11 × 15x P/E

Bull Case $48.19 103.3% upside ($48.19 - $23.70) / $23.70 = 103.3% $3.11 × 18x P/E

Adjust Assumptions

P/E Multiple

15.2x

Adjusted EPS

3.11$

Key Value Driver

Normalized P/E multiple (15x base case)

Implied Market Multiple 7.6x

Plain-Language Summary

Our base-case estimate uses a valuation based on adjusted earnings per share and a normalized price-to-earnings multiple. We then blend that result with the average analyst price target of $27.13 from 62 analysts, using a 35% weight on analyst consensus. That produces an estimated intrinsic value of $40.15 per share.

Warnings

ℹ Wall Street's average price target is $27.13 (from 62 analysts). Our estimate is 74% above the consensus -- consider that gap carefully.

Key Risks

Growth DCF inappropriate — terminal value assumptions dominate
EV/EBITDA misleading for regulated businesses where capex is mandated
Regulatory risk is a fat tail not visible in normal multiples